The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cabozantinib Market Research Report 2025
Synopsis
Cabozantinib, sold under the brand-name Cabometyx and Cometriq, is a medication used to treat medullary thyroid cancer and a second line treatment for renal cell carcinoma among others. It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET. It was discovered and developed by Exelixis Inc.
The global Cabozantinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cabozantinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cabozantinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Cabozantinib include Exelixis, Tecoland Corporation, Fermion Oy, Sun Pharmaceutical Industries Limit, MSN Laboratories Pvt Ltd, Shanghai Hope Chem, Hetero Drugs Limited, Huateng Pharmaceutical Co. and Bio Nova Pharmaceuticals Private Limited, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cabozantinib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cabozantinib.
Report Scope
The Cabozantinib market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cabozantinib market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cabozantinib manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Exelixis
Tecoland Corporation
Fermion Oy
Sun Pharmaceutical Industries Limit
MSN Laboratories Pvt Ltd
Shanghai Hope Chem
Hetero Drugs Limited
Huateng Pharmaceutical Co.
Bio Nova Pharmaceuticals Private Limited
AlchemyPharm
Segment by Type
Capsule
Tablet
Segment by Application
Medullary Thyroid Cancer
Renal Cell Carcinoma
Hepatocellular Carcinoma
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cabozantinib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cabozantinib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Cabozantinib, sold under the brand-name Cabometyx and Cometriq, is a medication used to treat medullary thyroid cancer and a second line treatment for renal cell carcinoma among others. It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET. It was discovered and developed by Exelixis Inc.
The global Cabozantinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cabozantinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cabozantinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Cabozantinib include Exelixis, Tecoland Corporation, Fermion Oy, Sun Pharmaceutical Industries Limit, MSN Laboratories Pvt Ltd, Shanghai Hope Chem, Hetero Drugs Limited, Huateng Pharmaceutical Co. and Bio Nova Pharmaceuticals Private Limited, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cabozantinib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cabozantinib.
Report Scope
The Cabozantinib market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cabozantinib market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cabozantinib manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Exelixis
Tecoland Corporation
Fermion Oy
Sun Pharmaceutical Industries Limit
MSN Laboratories Pvt Ltd
Shanghai Hope Chem
Hetero Drugs Limited
Huateng Pharmaceutical Co.
Bio Nova Pharmaceuticals Private Limited
AlchemyPharm
Segment by Type
Capsule
Tablet
Segment by Application
Medullary Thyroid Cancer
Renal Cell Carcinoma
Hepatocellular Carcinoma
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cabozantinib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cabozantinib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Cabozantinib Market Overview
1.1 Product Overview and Scope of Cabozantinib
1.2 Cabozantinib Segment by Type
1.2.1 Global Cabozantinib Market Value Comparison by Type (2024-2030)
1.2.2 Capsule
1.2.3 Tablet
1.3 Cabozantinib Segment by Application
1.3.1 Global Cabozantinib Market Value by Application: (2024-2030)
1.3.2 Medullary Thyroid Cancer
1.3.3 Renal Cell Carcinoma
1.3.4 Hepatocellular Carcinoma
1.4 Global Cabozantinib Market Size Estimates and Forecasts
1.4.1 Global Cabozantinib Revenue 2019-2030
1.4.2 Global Cabozantinib Sales 2019-2030
1.4.3 Global Cabozantinib Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Cabozantinib Market Competition by Manufacturers
2.1 Global Cabozantinib Sales Market Share by Manufacturers (2019-2024)
2.2 Global Cabozantinib Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Cabozantinib Average Price by Manufacturers (2019-2024)
2.4 Global Cabozantinib Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cabozantinib, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cabozantinib, Product Type & Application
2.7 Cabozantinib Market Competitive Situation and Trends
2.7.1 Cabozantinib Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cabozantinib Players Market Share by Revenue
2.7.3 Global Cabozantinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cabozantinib Retrospective Market Scenario by Region
3.1 Global Cabozantinib Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Cabozantinib Global Cabozantinib Sales by Region: 2019-2030
3.2.1 Global Cabozantinib Sales by Region: 2019-2024
3.2.2 Global Cabozantinib Sales by Region: 2025-2030
3.3 Global Cabozantinib Global Cabozantinib Revenue by Region: 2019-2030
3.3.1 Global Cabozantinib Revenue by Region: 2019-2024
3.3.2 Global Cabozantinib Revenue by Region: 2025-2030
3.4 North America Cabozantinib Market Facts & Figures by Country
3.4.1 North America Cabozantinib Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Cabozantinib Sales by Country (2019-2030)
3.4.3 North America Cabozantinib Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cabozantinib Market Facts & Figures by Country
3.5.1 Europe Cabozantinib Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Cabozantinib Sales by Country (2019-2030)
3.5.3 Europe Cabozantinib Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cabozantinib Market Facts & Figures by Country
3.6.1 Asia Pacific Cabozantinib Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Cabozantinib Sales by Country (2019-2030)
3.6.3 Asia Pacific Cabozantinib Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cabozantinib Market Facts & Figures by Country
3.7.1 Latin America Cabozantinib Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Cabozantinib Sales by Country (2019-2030)
3.7.3 Latin America Cabozantinib Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cabozantinib Market Facts & Figures by Country
3.8.1 Middle East and Africa Cabozantinib Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Cabozantinib Sales by Country (2019-2030)
3.8.3 Middle East and Africa Cabozantinib Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cabozantinib Sales by Type (2019-2030)
4.1.1 Global Cabozantinib Sales by Type (2019-2024)
4.1.2 Global Cabozantinib Sales by Type (2025-2030)
4.1.3 Global Cabozantinib Sales Market Share by Type (2019-2030)
4.2 Global Cabozantinib Revenue by Type (2019-2030)
4.2.1 Global Cabozantinib Revenue by Type (2019-2024)
4.2.2 Global Cabozantinib Revenue by Type (2025-2030)
4.2.3 Global Cabozantinib Revenue Market Share by Type (2019-2030)
4.3 Global Cabozantinib Price by Type (2019-2030)
5 Segment by Application
5.1 Global Cabozantinib Sales by Application (2019-2030)
5.1.1 Global Cabozantinib Sales by Application (2019-2024)
5.1.2 Global Cabozantinib Sales by Application (2025-2030)
5.1.3 Global Cabozantinib Sales Market Share by Application (2019-2030)
5.2 Global Cabozantinib Revenue by Application (2019-2030)
5.2.1 Global Cabozantinib Revenue by Application (2019-2024)
5.2.2 Global Cabozantinib Revenue by Application (2025-2030)
5.2.3 Global Cabozantinib Revenue Market Share by Application (2019-2030)
5.3 Global Cabozantinib Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Exelixis
6.1.1 Exelixis Corporation Information
6.1.2 Exelixis Description and Business Overview
6.1.3 Exelixis Cabozantinib Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Exelixis Cabozantinib Product Portfolio
6.1.5 Exelixis Recent Developments/Updates
6.2 Tecoland Corporation
6.2.1 Tecoland Corporation Corporation Information
6.2.2 Tecoland Corporation Description and Business Overview
6.2.3 Tecoland Corporation Cabozantinib Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Tecoland Corporation Cabozantinib Product Portfolio
6.2.5 Tecoland Corporation Recent Developments/Updates
6.3 Fermion Oy
6.3.1 Fermion Oy Corporation Information
6.3.2 Fermion Oy Description and Business Overview
6.3.3 Fermion Oy Cabozantinib Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Fermion Oy Cabozantinib Product Portfolio
6.3.5 Fermion Oy Recent Developments/Updates
6.4 Sun Pharmaceutical Industries Limit
6.4.1 Sun Pharmaceutical Industries Limit Corporation Information
6.4.2 Sun Pharmaceutical Industries Limit Description and Business Overview
6.4.3 Sun Pharmaceutical Industries Limit Cabozantinib Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sun Pharmaceutical Industries Limit Cabozantinib Product Portfolio
6.4.5 Sun Pharmaceutical Industries Limit Recent Developments/Updates
6.5 MSN Laboratories Pvt Ltd
6.5.1 MSN Laboratories Pvt Ltd Corporation Information
6.5.2 MSN Laboratories Pvt Ltd Description and Business Overview
6.5.3 MSN Laboratories Pvt Ltd Cabozantinib Sales, Revenue and Gross Margin (2019-2024)
6.5.4 MSN Laboratories Pvt Ltd Cabozantinib Product Portfolio
6.5.5 MSN Laboratories Pvt Ltd Recent Developments/Updates
6.6 Shanghai Hope Chem
6.6.1 Shanghai Hope Chem Corporation Information
6.6.2 Shanghai Hope Chem Description and Business Overview
6.6.3 Shanghai Hope Chem Cabozantinib Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Shanghai Hope Chem Cabozantinib Product Portfolio
6.6.5 Shanghai Hope Chem Recent Developments/Updates
6.7 Hetero Drugs Limited
6.6.1 Hetero Drugs Limited Corporation Information
6.6.2 Hetero Drugs Limited Description and Business Overview
6.6.3 Hetero Drugs Limited Cabozantinib Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hetero Drugs Limited Cabozantinib Product Portfolio
6.7.5 Hetero Drugs Limited Recent Developments/Updates
6.8 Huateng Pharmaceutical Co.
6.8.1 Huateng Pharmaceutical Co. Corporation Information
6.8.2 Huateng Pharmaceutical Co. Description and Business Overview
6.8.3 Huateng Pharmaceutical Co. Cabozantinib Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Huateng Pharmaceutical Co. Cabozantinib Product Portfolio
6.8.5 Huateng Pharmaceutical Co. Recent Developments/Updates
6.9 Bio Nova Pharmaceuticals Private Limited
6.9.1 Bio Nova Pharmaceuticals Private Limited Corporation Information
6.9.2 Bio Nova Pharmaceuticals Private Limited Description and Business Overview
6.9.3 Bio Nova Pharmaceuticals Private Limited Cabozantinib Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bio Nova Pharmaceuticals Private Limited Cabozantinib Product Portfolio
6.9.5 Bio Nova Pharmaceuticals Private Limited Recent Developments/Updates
6.10 AlchemyPharm
6.10.1 AlchemyPharm Corporation Information
6.10.2 AlchemyPharm Description and Business Overview
6.10.3 AlchemyPharm Cabozantinib Sales, Revenue and Gross Margin (2019-2024)
6.10.4 AlchemyPharm Cabozantinib Product Portfolio
6.10.5 AlchemyPharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cabozantinib Industry Chain Analysis
7.2 Cabozantinib Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cabozantinib Production Mode & Process
7.4 Cabozantinib Sales and Marketing
7.4.1 Cabozantinib Sales Channels
7.4.2 Cabozantinib Distributors
7.5 Cabozantinib Customers
8 Cabozantinib Market Dynamics
8.1 Cabozantinib Industry Trends
8.2 Cabozantinib Market Drivers
8.3 Cabozantinib Market Challenges
8.4 Cabozantinib Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Cabozantinib Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Cabozantinib Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Cabozantinib Market Competitive Situation by Manufacturers in 2023
Table 4. Global Cabozantinib Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Cabozantinib Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Cabozantinib Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Cabozantinib Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Cabozantinib Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Cabozantinib, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Cabozantinib, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cabozantinib, Product Type & Application
Table 12. Global Key Manufacturers of Cabozantinib, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cabozantinib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cabozantinib as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cabozantinib Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Cabozantinib Sales by Region (2019-2024) & (K Units)
Table 18. Global Cabozantinib Sales Market Share by Region (2019-2024)
Table 19. Global Cabozantinib Sales by Region (2025-2030) & (K Units)
Table 20. Global Cabozantinib Sales Market Share by Region (2025-2030)
Table 21. Global Cabozantinib Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Cabozantinib Revenue Market Share by Region (2019-2024)
Table 23. Global Cabozantinib Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Cabozantinib Revenue Market Share by Region (2025-2030)
Table 25. North America Cabozantinib Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Cabozantinib Sales by Country (2019-2024) & (K Units)
Table 27. North America Cabozantinib Sales by Country (2025-2030) & (K Units)
Table 28. North America Cabozantinib Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Cabozantinib Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Cabozantinib Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Cabozantinib Sales by Country (2019-2024) & (K Units)
Table 32. Europe Cabozantinib Sales by Country (2025-2030) & (K Units)
Table 33. Europe Cabozantinib Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Cabozantinib Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Cabozantinib Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Cabozantinib Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Cabozantinib Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Cabozantinib Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Cabozantinib Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Cabozantinib Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Cabozantinib Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Cabozantinib Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Cabozantinib Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Cabozantinib Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Cabozantinib Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Cabozantinib Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Cabozantinib Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Cabozantinib Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Cabozantinib Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Cabozantinib Sales (K Units) by Type (2019-2024)
Table 51. Global Cabozantinib Sales (K Units) by Type (2025-2030)
Table 52. Global Cabozantinib Sales Market Share by Type (2019-2024)
Table 53. Global Cabozantinib Sales Market Share by Type (2025-2030)
Table 54. Global Cabozantinib Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Cabozantinib Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Cabozantinib Revenue Market Share by Type (2019-2024)
Table 57. Global Cabozantinib Revenue Market Share by Type (2025-2030)
Table 58. Global Cabozantinib Price (US$/Unit) by Type (2019-2024)
Table 59. Global Cabozantinib Price (US$/Unit) by Type (2025-2030)
Table 60. Global Cabozantinib Sales (K Units) by Application (2019-2024)
Table 61. Global Cabozantinib Sales (K Units) by Application (2025-2030)
Table 62. Global Cabozantinib Sales Market Share by Application (2019-2024)
Table 63. Global Cabozantinib Sales Market Share by Application (2025-2030)
Table 64. Global Cabozantinib Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Cabozantinib Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Cabozantinib Revenue Market Share by Application (2019-2024)
Table 67. Global Cabozantinib Revenue Market Share by Application (2025-2030)
Table 68. Global Cabozantinib Price (US$/Unit) by Application (2019-2024)
Table 69. Global Cabozantinib Price (US$/Unit) by Application (2025-2030)
Table 70. Exelixis Corporation Information
Table 71. Exelixis Description and Business Overview
Table 72. Exelixis Cabozantinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Exelixis Cabozantinib Product
Table 74. Exelixis Recent Developments/Updates
Table 75. Tecoland Corporation Corporation Information
Table 76. Tecoland Corporation Description and Business Overview
Table 77. Tecoland Corporation Cabozantinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Tecoland Corporation Cabozantinib Product
Table 79. Tecoland Corporation Recent Developments/Updates
Table 80. Fermion Oy Corporation Information
Table 81. Fermion Oy Description and Business Overview
Table 82. Fermion Oy Cabozantinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Fermion Oy Cabozantinib Product
Table 84. Fermion Oy Recent Developments/Updates
Table 85. Sun Pharmaceutical Industries Limit Corporation Information
Table 86. Sun Pharmaceutical Industries Limit Description and Business Overview
Table 87. Sun Pharmaceutical Industries Limit Cabozantinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Sun Pharmaceutical Industries Limit Cabozantinib Product
Table 89. Sun Pharmaceutical Industries Limit Recent Developments/Updates
Table 90. MSN Laboratories Pvt Ltd Corporation Information
Table 91. MSN Laboratories Pvt Ltd Description and Business Overview
Table 92. MSN Laboratories Pvt Ltd Cabozantinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. MSN Laboratories Pvt Ltd Cabozantinib Product
Table 94. MSN Laboratories Pvt Ltd Recent Developments/Updates
Table 95. Shanghai Hope Chem Corporation Information
Table 96. Shanghai Hope Chem Description and Business Overview
Table 97. Shanghai Hope Chem Cabozantinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Shanghai Hope Chem Cabozantinib Product
Table 99. Shanghai Hope Chem Recent Developments/Updates
Table 100. Hetero Drugs Limited Corporation Information
Table 101. Hetero Drugs Limited Description and Business Overview
Table 102. Hetero Drugs Limited Cabozantinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Hetero Drugs Limited Cabozantinib Product
Table 104. Hetero Drugs Limited Recent Developments/Updates
Table 105. Huateng Pharmaceutical Co. Corporation Information
Table 106. Huateng Pharmaceutical Co. Description and Business Overview
Table 107. Huateng Pharmaceutical Co. Cabozantinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Huateng Pharmaceutical Co. Cabozantinib Product
Table 109. Huateng Pharmaceutical Co. Recent Developments/Updates
Table 110. Bio Nova Pharmaceuticals Private Limited Corporation Information
Table 111. Bio Nova Pharmaceuticals Private Limited Description and Business Overview
Table 112. Bio Nova Pharmaceuticals Private Limited Cabozantinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Bio Nova Pharmaceuticals Private Limited Cabozantinib Product
Table 114. Bio Nova Pharmaceuticals Private Limited Recent Developments/Updates
Table 115. AlchemyPharm Corporation Information
Table 116. AlchemyPharm Description and Business Overview
Table 117. AlchemyPharm Cabozantinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. AlchemyPharm Cabozantinib Product
Table 119. AlchemyPharm Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Cabozantinib Distributors List
Table 123. Cabozantinib Customers List
Table 124. Cabozantinib Market Trends
Table 125. Cabozantinib Market Drivers
Table 126. Cabozantinib Market Challenges
Table 127. Cabozantinib Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Cabozantinib
Figure 2. Global Cabozantinib Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Cabozantinib Market Share by Type in 2023 & 2030
Figure 4. Capsule Product Picture
Figure 5. Tablet Product Picture
Figure 6. Global Cabozantinib Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Cabozantinib Market Share by Application in 2023 & 2030
Figure 8. Medullary Thyroid Cancer
Figure 9. Renal Cell Carcinoma
Figure 10. Hepatocellular Carcinoma
Figure 11. Global Cabozantinib Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Cabozantinib Market Size (2019-2030) & (US$ Million)
Figure 13. Global Cabozantinib Sales (2019-2030) & (K Units)
Figure 14. Global Cabozantinib Average Price (US$/Unit) & (2019-2030)
Figure 15. Cabozantinib Report Years Considered
Figure 16. Cabozantinib Sales Share by Manufacturers in 2023
Figure 17. Global Cabozantinib Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Cabozantinib Players: Market Share by Revenue in 2023
Figure 19. Cabozantinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Cabozantinib Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Cabozantinib Sales Market Share by Country (2019-2030)
Figure 22. North America Cabozantinib Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Cabozantinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Cabozantinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Cabozantinib Sales Market Share by Country (2019-2030)
Figure 26. Europe Cabozantinib Revenue Market Share by Country (2019-2030)
Figure 27. Germany Cabozantinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Cabozantinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Cabozantinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Cabozantinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Cabozantinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Cabozantinib Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Cabozantinib Revenue Market Share by Region (2019-2030)
Figure 34. China Cabozantinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Cabozantinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Cabozantinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Cabozantinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Cabozantinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Cabozantinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Cabozantinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Cabozantinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Cabozantinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Cabozantinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Cabozantinib Sales Market Share by Country (2019-2030)
Figure 45. Latin America Cabozantinib Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Cabozantinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Cabozantinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Cabozantinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Cabozantinib Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Cabozantinib Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Cabozantinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Cabozantinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Cabozantinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Cabozantinib by Type (2019-2030)
Figure 55. Global Revenue Market Share of Cabozantinib by Type (2019-2030)
Figure 56. Global Cabozantinib Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Cabozantinib by Application (2019-2030)
Figure 58. Global Revenue Market Share of Cabozantinib by Application (2019-2030)
Figure 59. Global Cabozantinib Price (US$/Unit) by Application (2019-2030)
Figure 60. Cabozantinib Value Chain
Figure 61. Cabozantinib Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
